Center for Cancer and Blood Disorders
In research, Center for Cancer and Blood Disorders stands highest in Medicine (#4,306 of 10,443 worldwide) and Health Sciences (#5,711 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology, Genetics and Oncology — Hematology is 42.6× its share of world research.
- World rank, 2022–2025
- #9,379 of 28,054 · #10,309 all time
- Rank in United States
- #1,252 of 4,192
- Research works
- 843 ▲ 34% vs 2013–17
- Citations
- 22k 26.6 per fractional work
- Top-10% rate
- 17.7% record average 16.5%
- Open access
- 43% world 28%
What is Center for Cancer and Blood Disorders known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,306 of 10,443 | 16.0% | 156 | #3038 | |
| Health SciencesDomain | #5,711 of 11,982 | 16.0% | 164 | #4047 |
Each strip is that field’s whole ranked pool, with the notch where Center for Cancer and Blood Disorders sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Center for Cancer and Blood Disorders specialise in?
Where its research is concentrated relative to its size: Hematology takes 42.6× the share of its output that it takes of world research.
- HematologySubfield · 27.9 works43×
- GeneticsSubfield · 21.8 works37×
- OncologySubfield · 23.2 works9.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.5×. Every wedge is a field page.
- Immunology and Microbiology 5.5×
- Medicine 3.8×
- Biochemistry, Genetics and Molecular Biology 2.3×
- Health Professions 1.2×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Nursing 0.5×
- Neuroscience 0.5×
- Psychology 0.3×
- Economics, Econometrics and Finance 0.2×
- Chemistry 0.2×
- Engineering 0.1×
- Social Sciences 0.1×
- Business, Management and Accounting 0.1×
- Physics and Astronomy 0.1×
- Dentistry 0.0×
- Materials Science 0.0×
- Computer Science 0.0×
- Environmental Science 0.0×
- Arts and Humanities 0.0×
- Mathematics 0.0×
- Decision Sciences 0.0×
Who are the top researchers at Center for Cancer and Blood Disorders?
Ranked on the composite score, Ray D. Page, Ralph V. Boccia and Sue P. Heiney lead among researchers whose main affiliation is Center for Cancer and Blood Disorders.
- 1 Ray D. Page United States · #451,277 worldwide 57 citations · 26 works
- 2 Ralph V. Boccia United States · #1,192,306 worldwide 21 citations · 27 works
- 3 Sue P. Heiney United States · #1,203,136 worldwide 26 citations · 24 works
Which keywords describe research at Center for Cancer and Blood Disorders?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Immunotherapy, Lymphoma, Pulmonary Hypertension, Sickle-cell Disease, Thalassemia, Hematopoietic Stem Cells and Cancer Immunotherapy.
- Iron Regulation
- Hodgkin's Lymphoma
- Molecular Profiling
- Prognosis
- PET Imaging
- Iron Deficiency
- Radiotherapy
- AML
- Acute Lymphoblastic Leukemia
- Minimal Residual Disease
- Childhood Cancer Survivor Study
- Chimeric Antigen Receptor
- Genetic Mutations
- Tumor Regression
- Leukemia
- Chemotherapy
- Thalassemia
- Inflammation
- Lymphoma
- Immunotherapy
- Prognostic Factors
- Epidemiology
- Pulmonary Hypertension
- Sickle-cell Disease
- Hematopoietic Stem Cells
- Cancer Immunotherapy
- Cancer
- Health-related Quality of Life
- CAR T Cells
- Anemia
- Pediatric Quality of Life Inventory
- Rituximab
- Childhood Cancer
- Acute Myeloid Leukemia
- Erythropoiesis
- Staging System
- Classification
- Gene Expression Profiling
- Genetic Pathogenesis
- Hepcidin
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Prognostic Factors22▲ 23×13 topics
- Immunotherapy21▲ 14×14 topics
- Epidemiology19▲ 2.2×42 topics
- Lymphoma15▲ 44×3 topics
- Pulmonary Hypertension13▲ 43×3 topics
- Inflammation13▲ 2.9×34 topics
- Sickle-cell Disease13▲ 138×1 topic
- Thalassemia13▲ 138×1 topic
- Hematopoietic Stem Cells12▲ 64×3 topics
- Chemotherapy11▲ 7.5×21 topics
- Cancer Immunotherapy11▲ 34×3 topics
- Leukemia11▲ 59×2 topics
- Cancer10▲ 3.6×28 topics
- Tumor Regression10▲ 44×2 topics
- Health-related Quality of Life10▲ 20×4 topics
- Genetic Mutations10▲ 11×14 topics
- CAR T Cells10▲ 63×1 topic
- Chimeric Antigen Receptor10▲ 63×1 topic
- Anemia9▲ 45×4 topics
- Childhood Cancer Survivor Study9▲ 91×1 topic
- Pediatric Quality of Life Inventory9▲ 91×1 topic
- Minimal Residual Disease8▲ 58×2 topics
- Rituximab8▲ 23×2 topics
- Acute Lymphoblastic Leukemia7▲ 100×1 topic
- Childhood Cancer7▲ 100×1 topic
- AML7▲ 63×1 topic
- Acute Myeloid Leukemia7▲ 63×1 topic
- Radiotherapy6▲ 7.7×11 topics
- Erythropoiesis6▲ 45×2 topics
- Iron Deficiency6▲ 51×2 topics
- Staging System6▲ 42×2 topics
- PET Imaging6▲ 15×4 topics
- Classification5▲ 5.5×4 topics
- Prognosis5▲ 7.1×6 topics
- Gene Expression Profiling5▲ 27×2 topics
- Molecular Profiling5▲ 22×2 topics
- Genetic Pathogenesis5▲ 41×1 topic
- Hodgkin's Lymphoma5▲ 41×1 topic
- Hepcidin5▲ 55×1 topic
- Iron Regulation5▲ 55×1 topic
Which research topics does Center for Cancer and Blood Disorders publish most on?
By volume in 2022–2025: Hemoglobinopathies and Related Disorders, CAR-T cell therapy research, Childhood Cancer Survivors' Quality of Life and Acute Lymphoblastic Leukemia research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemoglobinopathies and Related Disorders Genetics 13 works
- 2 CAR-T cell therapy research Oncology 10 works
- 3 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 9 works
- 4 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 7 works
- 5 Acute Myeloid Leukemia Research Hematology 7 works
- 6 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 5 works
- 7 Iron Metabolism and Disorders Hematology 5 works
- 8 Hematopoietic Stem Cell Transplantation Hematology 4 works
- 9 Neuroblastoma Research and Treatments Neurology 4 works
- 10 Glioma Diagnosis and Treatment Genetics 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Center for Cancer and Blood Disorders's research output changed?
Output in 2018–2022 was 34% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Fort Worth
- Texas Christian University
- University of North Texas Health Science Center
- Texas A&M University School of Law
- Alcon (United States)
- Fort Worth Library
- John Peter Smith Hospital
- Cook Children's Medical Center
- American Airlines (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.